Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07444879) titled 'IL-33, sST2, and CRP in Panic Disorder' on Feb. 25.

Study Type: Observational

Primary Sponsor: Elazig Mental Health and Diseases Hospital

Condition: Panic Disorder

Recruitment Status: Recruiting

Date of First Enrollment: July 7, 2025

Target Sample Size: 80

Countries of Recruitment: Turkey (Turkiye)

To know more, visit https://clinicaltrials.gov/study/NCT07444879

Published by HT Digital Content Services with permission from Health Daily Digest....